Science of DME Newsfeed Archived News (English) Anti-VEGF Agent Ranibizumab Gets FDA Breakthrough Therapy Designation for Diabetic Retinopathy Ci spiace, ma questo articolo è disponibile soltanto in English. Translations powered by Google Translate